For: | Chen T, Wu F, Chen FM, Tian J, Qu S. Variations of very low-density lipoprotein receptor subtype expression in gastrointestinal adenocarcinoma cells with various differentiations. World J Gastroenterol 2005; 11(18): 2817-2821 [PMID: 15884130 DOI: 10.3748/wjg.v11.i18.2817] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i18/2817.htm |
Number | Citing Articles |
1 |
Yoshitaka Sekine, Hidekazu Koike, Takamitsu Nakano, Katsuyuki Nakajima, Sadao Takahashi, Kazuhiro Suzuki. Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor. Cancer Epidemiology 2009; 33(1): 16 doi: 10.1016/j.canep.2009.04.004
|
2 |
Lei He, Yanjun Lu, Jianli Guo. Type II VLDLR promotes cell migration by up-regulation of VEGF, MMP2 and MMP7 in breast cancer cells. The Chinese-German Journal of Clinical Oncology 2013; 12(8): 374 doi: 10.1007/s10330-013-1218-7
|
3 |
Abbas Mosapour, Fatemeh Soghra Karami Tehrani, Morteza Atri. Expression level of VLDL receptor and VLDL-c levels in the malignant and benign breast tumors: The correlation with miRNA-4465 and miRNA-1297. Molecular and Cellular Probes 2020; 53: 101624 doi: 10.1016/j.mcp.2020.101624
|
4 |
Gyu Young Pih, Eun Jeong Gong, Ji Young Choi, Min-Ju Kim, Ji Yong Ahn, Jaewon Choe, Suh Eun Bae, Hye-Sook Chang, Hee Kyong Na, Jeong Hoon Lee, Kee Wook Jung, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung. Associations of Serum Lipid Level with Gastric Cancer Risk, Pathology, and Prognosis. Cancer Research and Treatment 2021; 53(2): 445 doi: 10.4143/crt.2020.599
|
5 |
Rabeah Al-Temaimi, Tuan Tan, Makia Marafie, Jean Thiery, Philip Quirke, Fahd Al-Mulla. Identification of 42 Genes Linked to Stage II Colorectal Cancer Metastatic Relapse. International Journal of Molecular Sciences 2016; 17(5): 598 doi: 10.3390/ijms17050598
|
6 |
Pu Yang, Zhiguo Liu, Hongxing Wang, Jun Tian, Yinghong Li, Yiqiang Zong, Shen Qu. Enhanced activity of very low density lipoprotein receptor II promotes SGC7901 cell proliferation and migration. Life Sciences 2009; 84(13-14): 402 doi: 10.1016/j.lfs.2008.12.020
|
7 |
H Takada, I Imoto, H Tsuda, Y Nakanishi, C Sakakura, S Mitsufuji, S Hirohashi, J Inazawa. Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis. Oncogene 2006; 25(49): 6554 doi: 10.1038/sj.onc.1209657
|
8 |
Marion Dubuissez, Perrine Faiderbe, Sébastien Pinte, Vanessa Dehennaut, Brian R. Rood, Dominique Leprince. The Reelin receptors ApoER2 and VLDLR are direct target genes of HIC1 (Hypermethylated In Cancer 1). Biochemical and Biophysical Research Communications 2013; 440(3): 424 doi: 10.1016/j.bbrc.2013.09.091
|
9 |
Mengying Yang, Yajing Zhan, Zhijie Hou, Chunli Wang, Wenjun Fan, Tao Guo, Zhuoshi Li, Lei Fang, Shasha Lv, Sisi Li, Chundong Gu, Mingliang Ye, Hongqiang Qin, Quentin Liu, Xiaonan Cui. VLDLR disturbs quiescence of breast cancer stem cells in a ligand-independent function. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.887035
|
10 |
Yong Di, Zhiguo Liu, Jun Tian, Yiqiang Zong, Pu Yang, Shen Qu. TFPI or uPA–PAI‐1 complex affect cell function through expression variation of type II very low density lipoprotein receptor. FEBS Letters 2010; 584(15): 3469 doi: 10.1016/j.febslet.2010.07.005
|
11 |
Qian Chen, Yusuke Takahashi, Kazuhiro Oka, Jian-xing Ma. Functional Differences of Very-Low-Density Lipoprotein Receptor Splice Variants in Regulating Wnt Signaling. Molecular and Cellular Biology 2016; 36(20): 2645 doi: 10.1128/MCB.00235-16
|
12 |
Evan Maestri, Kalina Duszka, Vladimir A. Kuznetsov. Immunity Depletion, Telomere Imbalance, and Cancer-Associated Metabolism Pathway Aberrations in Intestinal Mucosa upon Short-Term Caloric Restriction. Cancers 2021; 13(13): 3180 doi: 10.3390/cancers13133180
|